Mass spectrometry proteomics creates complex data representing the peptide/protein contents of biological samples. Various types of machine learning have been central to computational methods used to identify peptides from tandem mass spectra and numerous other aspects of the data analysis process. As deep learning has emerged as a powerful machine learning method for modeling and interpreting data, computational proteomics researchers have leveraged large publicly available data sets to train machine learning models to predict peptide fragmentation spectra and liquid chromatography retention time. Resources like proteomicsML offer extensive demonstrative tutorials for these learning tasks and are closing the gap between the proteomics and machine learning communities. However, in these and other educational materials on deep learning, the critical step of preparing data for learning is frequently omitted. Prior to learning, peptide strings must be converted into a numeric format─an embedding. There are many different peptide embeddings, and some vastly outperform others. Yet the process for creating an embedding, and also the rationale for choosing a specific embedding, is rarely discussed in our proteomics literature. In this technical note, we introduce four Google Colab notebooks to teach peptide embeddings. The series walks users through five different peptide-embedding strategies─ from simplistic single-number encodings to state-of-the-art pretrained embeddings─ through both code examples and narrative descriptions. The final notebook compares the five embeddings in a head-to-head benchmark. By making these notebooks free, we hope to lower the barrier for researchers who want to bring modern deep learning into their proteomics workflows.

Decoy-based methods are a popular choice for the statistical validation of peptide detection in tandem mass spectrometry and proteomics data. Such methods can achieve a substantial boost in statistical power when coupled with postprocessors such as Percolator that use auxiliary features to learn a better-discriminating scoring function. However, we recently showed that Percolator can struggle to control the false discovery rate (FDR) when reporting the list of discovered peptides. To address this problem, we introduce Percolator-RESET, which is an adaptation of our recently developed RESET meta-procedure to the peptide detection problem. Specifically, Percolator-RESET fuses Percolator's iterative SVM training procedure with RESET's general framework to provide valid false discovery rate control. Percolator-RESET operates in both a standard single-decoy mode and a two-decoy mode, with the latter requiring the generation of two decoys per target. We demonstrate that Percolator-RESET controls the FDR in both modes, both theoretically and empirically, while typically reporting only a marginally smaller number of discoveries than Percolator in the single-decoy mode. The two-decoy mode is marginally more powerful than both Percolator and the single-decoy mode and exhibits less variability than the latter.

Here, we introduce Met-ID, a graphical user interface software designed to efficiently identify metabolites from MALDI-MSI data sets. Met-ID enables annotation of m/z features from any type of MALDI-MSI experiment, involving either derivatizing or conventional matrices. It utilizes structural information for derivatizing matrices to generate a subset of targets that contain only functional groups specific to the derivatization agent. The software is able to identify multiple derivatization sites on the same molecule, facilitating identification of the derivatized compound. This ability is exemplified by FMP-10, a reactive matrix that assists the covalent charge-tagging of molecules containing phenolic hydroxyl and/or primary or secondary amine groups. Met-ID also permits users to recalibrate data with known m/z ratios, boosting confidence in mass match results. Furthermore, Met-ID includes a database featuring MS2 spectra of numerous chemical standards, consisting of neurotransmitters and metabolites derivatized with FMP-10, alongside peaks for FMP-10 itself, all accessible directly through the software. The MS2 spectral database supports user-uploaded spectra and enables comparison of these spectra with user-provided tissue MS2 spectra for similarity assessment. Although initially installed with basic data, Met-ID is designed to be customizable, encouraging users to tailor the software to their specific needs. While several MSI-oriented software solutions exist, Met-ID combines both MS1 and MS2 functionalities. Developed in alignment with the FAIR Guiding Principles for scientific software, Met-ID is freely available as an open-source tool on GitHub, ensuring wide accessibility and collaboration.

Scientific discovery relies on innovative software as much as experimental methods, especially in proteomics, where computational tools are essential for mass spectrometer setup, data analysis, and interpretation. Since the introduction of SEQUEST, proteomics software has grown into a complex ecosystem of algorithms, predictive models, and workflows, but the field faces challenges, including the increasing complexity of mass spectrometry data, limited reproducibility due to proprietary software, and difficulties integrating with other omics disciplines. Closed-source, platform-specific tools exacerbate these issues by restricting innovation, creating inefficiencies, and imposing hidden costs on the community. Open-source software (OSS), aligned with the FAIR Principles (Findable, Accessible, Interoperable, Reusable), offers a solution by promoting transparency, reproducibility, and community-driven development, which fosters collaboration and continuous improvement. In this manuscript, we explore the role of OSS in computational proteomics, its alignment with FAIR principles, and its potential to address challenges related to licensing, distribution, and standardization. Drawing on lessons from other omics fields, we present a vision for a future where OSS and FAIR principles underpin a transparent, accessible, and innovative proteomics community.

A fundamental challenge in mass spectrometry-based proteomics is determining which peptide generated a given MS2 spectrum. Peptide sequencing typically relies on matching spectra against a known sequence database, which in some applications is not available. Deep learning-based de novo sequencing can address this limitation by directly predicting peptide sequences from MS2 data. We have seen the application of the transformer architecture to de novo sequencing produce state-of-the-art results on the so-called nine-species benchmark. In this study, we propose an improved transformer encoder inspired by the heuristics used in the manual interpretation of spectra. We modify the attention mechanism with a learned bias based on pairwise mass differences, termed Pairwise Attention (PA). Adding PA improves average peptide precision at 100% coverage by 12.7% (5.9 percentage points) over our base transformer on the original nine-species benchmark. We have also achieved a 7.4% increase over the previously published model Casanovo. Our MS2 encoding strategy is largely orthogonal to other transformer-based models encoding MS2 spectra, enabling straightforward integration into existing deep-learning approaches. Our results show that integrating domain-specific knowledge into transformers boosts de novo sequencing performance.

A fundamental challenge in mass spectrometry-based proteomics is determining which peptide generated a given MS2 spectrum. Peptide sequencing typically relies on matching spectra against a known sequence database, which in some applications is not available. Deep learning-based de novo sequencing can address this limitation by directly predicting peptide sequences from MS2 data. We have seen the application of the transformer architecture to de novo sequencing produce state-of-the-art results on the so-called nine-species benchmark. In this study, we propose an improved transformer encoder inspired by the heuristics used in the manual interpretation of spectra. We modify the attention mechanism with a learned bias based on pairwise mass differences, termed Pairwise Attention (PA). Adding PA improves average peptide precision at 100% coverage by 12.7% (5.9 percentage points) over our base transformer on the original nine-species benchmark. We have also achieved a 7.4% increase over the previously published model Casanovo. Our MS2 encoding strategy is largely orthogonal to other transformer-based models encoding MS2 spectra, enabling straightforward integration into existing deep-learning approaches. Our results show that integrating domain-specific knowledge into transformers boosts de novo sequencing performance. 

In mass spectrometry-based proteomics, experts usually project data onto a single set of reference sequences, overlooking the influence of common haplotypes (combinations of genetic variants inherited together from a parent). We recently introduced ProHap, a tool for generating customized protein haplotype databases. Here, we present ProHap Explorer, a visualization interface designed to investigate the influence of common haplotypes on the human proteome. It enables users to explore haplotypes, their effects on protein sequences, and the identification of non-canonical peptides in public mass spectrometry datasets. The design builds on well-established representations in biological sequence analysis, ensuring familiarity for domain experts while integrating novel interactive elements tailored to proteogenomic data exploration. User interviews with proteomics experts confirmed the tool's utility, highlighting its ability to reveal whether haplotypes affect proteins of interest. By facilitating the intuitive exploration of proteogenomic variation, ProHap Explorer supports research in personalized medicine and the development of targeted therapies.

Antibodies are a major component of adaptive immunity against invading pathogens. Here, we explore possibilities for an analytical approach to characterize the antigen-specific antibody repertoire directly from the secreted proteins in convalescent serum. This approach aims to perform simultaneous antibody sequencing and epitope mapping using a combination of single particle cryo-electron microscopy (cryoEM) and bottom-up proteomics techniques based on mass spectrometry (LC-MS/MS). We evaluate the performance of the deep-learning tool ModelAngelo in determining de novo antibody sequences directly from reconstructed 3D volumes of antibody-antigen complexes. We demonstrate that while map quality is a critical bottleneck, it is possible to sequence antibody variable domains from cryoEM reconstructions with accuracies of up to 80-90%. While the rate of errors exceeds the typical levels of somatic hypermutation, we show that the ModelAngelo-derived sequences can be used to assign the used V-genes. This provides a functional guide to assemble de novo peptides from LC-MS/MS data more accurately and improves the tolerance to a background of polyclonal antibody sequences. Following this proof-of-principle, we discuss the feasibility and future directions of this approach to characterize antigen-specific antibody repertoires.

Interpreting electron cryo-microscopy (cryo-EM) maps with atomic models requires high levels of expertise and labour-intensive manual intervention in three-dimensional computer graphics programs^1,2. Here we present ModelAngelo, a machine-learning approach for automated atomic model building in cryo-EM maps. By combining information from the cryo-EM map with information from protein sequence and structure in a single graph neural network, ModelAngelo builds atomic models for proteins that are of similar quality to those generated by human experts. For nucleotides, ModelAngelo builds backbones with similar accuracy to those built by humans. By using its predicted amino acid probabilities for each residue in hidden Markov model sequence searches, ModelAngelo outperforms human experts in the identification of proteins with unknown sequences. ModelAngelo will therefore remove bottlenecks and increase objectivity in cryo-EM structure determination.